Search Results - "Cruickshank, Derek"

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial by Jacobs, Ian J, Prof, Menon, Usha, Prof, Ryan, Andy, PhD, Gentry-Maharaj, Aleksandra, PhD, Burnell, Matthew, PhD, Kalsi, Jatinderpal K, PhD, Amso, Nazar N, Prof, Apostolidou, Sophia, PhD, Benjamin, Elizabeth, FRCPath, Cruickshank, Derek, FRCOG, Crump, Danielle N, BSN, Davies, Susan K, RGN, Dawnay, Anne, PhD, Dobbs, Stephen, FRCOG, Fletcher, Gwendolen, DCR(R), Ford, Jeremy, MSc, Godfrey, Keith, FRCOG, Gunu, Richard, MSc, Habib, Mariam, PhD, Hallett, Rachel, PhD, Herod, Jonathan, MRCOG, Jenkins, Howard, FRCOG, Karpinskyj, Chloe, BSc, Leeson, Simon, FRCOG, Lewis, Sara J, MSc, Liston, William R, Lopes, Alberto, FRCOG, Mould, Tim, FRCOG, Murdoch, John, FRCOG, Oram, David, FRCOG, Rabideau, Dustin J, MSc, Reynolds, Karina, FRCOG, Scott, Ian, FRCOG, Seif, Mourad W, FRCOG, Sharma, Aarti, PhD, Singh, Naveena, FRCPath, Taylor, Julie, MSc, Warburton, Fiona, MSc, Widschwendter, Martin, Prof, Williamson, Karin, FRCOG, Woolas, Robert, MD, Fallowfield, Lesley, Prof, McGuire, Alistair J, Prof, Campbell, Stuart, Prof, Parmar, Mahesh, Prof, Skates, Steven J, PhD

“…Summary Background Ovarian cancer has a poor prognosis, with just 40% of patients surviving 5 years. We designed this trial to establish the effect of early…”
Get full text

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) by Menon, Usha, Dr, Gentry-Maharaj, Aleksandra, PhD, Hallett, Rachel, PhD, Ryan, Andy, PhD, Burnell, Matthew, PhD, Sharma, Aarti, MRCOG, Lewis, Sara, MSc, Davies, Susan, RGN, Philpott, Susan, MSc, Lopes, Alberto, FRCOG, Godfrey, Keith, FRCOG, Oram, David, FRCOG, Herod, Jonathan, MRCOG, Williamson, Karin, FRCOG, Seif, Mourad W, FRCOG, Scott, Ian, FRCOG, Mould, Tim, FRCOG, Woolas, Robert, MD, Murdoch, John, FRCOG, Dobbs, Stephen, MRCOG, Amso, Nazar N, PhD, Leeson, Simon, FRCOG, Cruickshank, Derek, FRCOG, Mcguire, Alistair, Prof, Campbell, Stuart, Prof, Fallowfield, Lesley, Prof, Singh, Naveena, FRCPath, Dawnay, Anne, PhD, Skates, Steven J, PhD, Parmar, Mahesh, Prof, Jacobs, Ian, Prof

“…Summary Background Ovarian cancer has a high case–fatality ratio, with most women not diagnosed until the disease is in its advanced stages. The United Kingdom…”
Get full text

Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort by Jacobs, Ian, Prof, Gentry-Maharaj, Aleksandra, PhD, Burnell, Matthew, PhD, Manchanda, Ranjit, MRCOG, Singh, Naveena, FRCPath, Sharma, Aarti, MRCOG, Ryan, Andy, PhD, Seif, Mourad W, PhD, Amso, Nazar N, PhD, Turner, Gillian, FRCR, Brunell, Carol, FRCR, Fletcher, Gwendolen, DMU, Rangar, Rani, FRCOG, Ford, Kathy, DCR Rad, Godfrey, Keith, FRCOG, Lopes, Alberto, FRCOG, Oram, David, FRCOG, Herod, Jonathan, MRCOG, Williamson, Karin, FRCOG, Scott, Ian, FRCOG, Jenkins, Howard, FRCOG, Mould, Tim, FRCOG, Woolas, Robert, MD, Murdoch, John, FRCOG, Dobbs, Stephen, FRCOG, Leeson, Simon, FRCOG, Cruickshank, Derek, FRCOG, Skates, Steven J, PhD, Fallowfield, Lesley, Prof, Parmar, Mahesh, Prof, Campbell, Stuart, Prof, Menon, Usha, Prof

“…Summary Background The increase in the worldwide incidence of endometrial cancer relates to rising obesity, falling fertility, and the ageing of the…”
Get full text

Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials by Burnell, Matthew, Gentry-Maharaj, Aleksandra, Ryan, Andy, Apostolidou, Sophia, Habib, Mariam, Kalsi, Jatinderpal, Skates, Steven, Parmar, Mahesh, Seif, Mourad W, Amso, Nazar N, Godfrey, Keith, Oram, David, Herod, Jonathan, Williamson, Karin, Jenkins, Howard, Mould, Tim, Woolas, Robert, Murdoch, John, Dobbs, Stephen, Leeson, Simon, Cruickshank, Derek, Campbell, Stuart, Fallowfield, Lesley, Jacobs, Ian, Menon, Usha

“…Participants in trials evaluating preventive interventions such as screening are on average healthier than the general population. To decrease this 'healthy…”
Get full text

Does the Interval from Primary Surgery to Chemotherapy Influence Progression-Free Survival in Ovarian Cancer? by Flynn, Paul M., Paul, Jim, Cruickshank, Derek J.

“…Objectives. The objective of this study was to determine whether the length of the interval from primary surgery to commencement of chemotherapy has any direct…”
Get full text

British Gynaecological Cancer Society (BGCS) epithelial ovarian/fallopian tube/primary peritoneal cancer guidelines: recommendations for practice by Fotopoulou, Christina, Hall, Marcia, Cruickshank, Derek, Gabra, Hani, Ganesan, Raji, Hughes, Cathy, Kehoe, Sean, Ledermann, Jonathan, Morrison, Jo, Naik, Raj, Rolland, Phil, Sundar, Sudha

Get full text

Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening by Menon, Usha, Ryan, Andy, Kalsi, Jatinderpal, Gentry-Maharaj, Aleksandra, Dawnay, Anne, Habib, Mariam, Apostolidou, Sophia, Singh, Naveena, Benjamin, Elizabeth, Burnell, Matthew, Davies, Susan, Sharma, Aarti, Gunu, Richard, Godfrey, Keith, Lopes, Alberto, Oram, David, Herod, Jonathan, Williamson, Karin, Seif, Mourad W, Jenkins, Howard, Mould, Tim, Woolas, Robert, Murdoch, John B, Dobbs, Stephen, Amso, Nazar N, Leeson, Simon, Cruickshank, Derek, Scott, Ian, Fallowfield, Lesley, Widschwendter, Martin, Reynolds, Karina, McGuire, Alistair, Campbell, Stuart, Parmar, Mahesh, Skates, Steven J, Jacobs, Ian

“…Cancer screening strategies have commonly adopted single-biomarker thresholds to identify abnormality. We investigated the impact of serial biomarker change…”
Get full text

Providing a quality service: direct referral from the cytology laboratory to the colposcopy clinic by Kew, Fiona M, Appleby, Denise, Whittaker, Vicki, Cruickshank, Derek J, Knott, Sandra

“…To compare the time taken for the referral process and the accuracy of referrals before and after a process review and the introduction of a system of direct…”
Get more information

The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) by Menon, Usha, McGuire, Alistair J, Raikou, Maria, Ryan, Andy, Davies, Susan K, Burnell, Matthew, Gentry-Maharaj, Aleksandra, Kalsi, Jatinderpal K, Singh, Naveena, Amso, Nazar N, Cruickshank, Derek, Dobbs, Stephen, Godfrey, Keith, Herod, Jonathan, Leeson, Simon, Mould, Tim, Murdoch, John, Oram, David, Scott, Ian, Seif, Mourad W, Williamson, Karin, Woolas, Robert, Fallowfield, Lesley, Campbell, Stuart, Skates, Steven J, Parmar, Mahesh, Jacobs, Ian J

“…Background: To assess the within-trial cost-effectiveness of an NHS ovarian cancer screening (OCS) programme using data from UKCTOCS and extrapolate results…”
Get full text

Management of Early Cervical Stromal Invasion FIGO Stage 1A1 When Margins Are Involved With Cervical Intraepithelial Neoplasia by Nicholson, Rachel C, Twigg, Jeremy, Roberts, Alison, Angelopoulos, Georgios, Cruickshank, Derek

“…Women with International Federation of Gynecology and Obstetrics stage 1A1 cervical carcinoma were evaluated to determine whether repeat excision for large…”
Get full text

Recruitment to multicentre trials—lessons from UKCTOCS: descriptive study by Menon, Usha, Gentry-Maharaj, Aleksandra, Ryan, Andy, Sharma, Aarti, Burnell, Matthew, Hallett, Rachel, Lewis, Sara, Lopez, Alberto, Godfrey, Keith, Oram, David, Herod, Jonathan, Williamson, Karin, Seif, Mourad, Scott, Ian, Mould, Tim, Woolas, Robert, Murdoch, John, Dobbs, Stephen, Amso, Nazar, Leeson, Simon, Cruickshank, Derek, McGuire, Ali, Campbell, Stuart, Fallowfield, Lesley, Skates, Steve, Parmar, Mahesh, Jacobs, Ian

“…Objective To describe the factors that contributed to successful recruitment of more than 200 000 women to the UK Collaborative Trial of Ovarian Cancer…”
Get full text

Ovarian Cancer Screening and Mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A Randomized Controlled Trial by Jacobs, Ian J, Menon, Usha, Ryan, Andy, Gentry-Maharaj, Aleksandra, Burnell, Matthew, Kalsi, Jatinderpal K, Amso, Nazar N, Apostolidou, Sophia, Benjamin, Elizabeth, Cruickshank, Derek, Crump, Danielle N, Davies, Susan K, Dawnay, Anne, Dobbs, Stephen, Fletcher, Gwendolen, Ford, Jeremy, Godfrey, Keith, Gunu, Richard, Habib, Mariam, Hallett, Rachel, Herod, Jonathan, Jenkins, Howard, Karpinskyj, Chloe, Leeson, Simon, Lewis, Sara J, Liston, William R, Lopes, Alberto, Mould, Tim, Murdoch, John, Oram, David, Rabideau, Dustin J, Reynolds, Karina, Scott, Ian, Seif, Mourad W, Sharma, Aarti, Singh, Naveena, Taylor, Julie, Warburton, Fiona, Widschwendter, Martin, Williamson, Karin, Woolas, Robert, Fallowfield, Lesley, McGuire, Alistair J, Campbell, Stuart, Parmar, Mahesh, Skates, Steven J

“…(Abstracted from Lancet 2016;387:945–956)Ovarian cancer (OC) is diagnosed in most women at an advanced disease stage when prognosis is poor and 5-year survival…”
Get full text

Reply by Flynn, Paul, Paul, Jim, Cruickshank, Derek

Get full text

Sensitivity and Specificity of Multimodal and Ultrasound Screening for Ovarian Cancer, and Stage Distribution of Detected Cancers: Results of the Prevalence Screen of the United Kingdom Collaborative Trial of Ovarian Cancer Screening by Menon, Usha, Gentry-Maharaj, Aleksandra, Hallett, Rachel, Ryan, Andy, Burnell, Matthew, Sharma, Aarti, Lewis, Sara, Davies, Susan, Philpott, Susan, Lopes, Alberto, Godfrey, Keith, Oram, David, Herod, Jonathatn, Williamson, Karin, Seif, Mourad W, Scott, Ian, Mould, Tim, Woolns, Robert, Murdoch, John, Dobbs, Stephen, Amso, Nazar N, Leeson, Simon, Cruickshank, Derek, Mcguire, Alistair, Campbell, Stuart, Fallowfield, Lesley, Singh, Naveena, Dawnay, Anne, Skates, Steven J, Parmar, Mahesh, Jacobs, Ian

“…Diagnosis of ovarian cancer at early stages increases the likelihood for effective treatment and long-term survival. Preliminary data from a randomized…”
Get full text

Flynn et al.: does the interval from primary surgery to chemotherapy influence progression-free survival in ovarian cancer? by Omura, George A.

Get full text

Medical termination of pregnancy at 63 to 83 days gestation by Gouk, Elaine V., Lincoln, Karen, Khair, Anu, Haslock, Joanne, Knight, June, Cruickshank, Derek J.

“…Objective To assess the efficacy of a medical regimen for the termination of pregnancy within the gestational age range of 63 to 83 days. Design Prospective…”
Get full text

Psychosexual impact of gynaecological malignancy by Kew, Fiona M, Nevin, James, Cruickshank, Derek J

“…University Hospital of North Tees, Hardwick, Stockton on Tees, Cleveland, TS19 8PE, UK. email: fiona{at}drsmiller.freeserve.co.uk (corresponding author) South…”
Get full text

Aetiological importance of ovulation in epithelial ovarian cancer : a population based study by CRUICKSHANK, D. J

Get full text

Screening for uterine neoplasms by Cruickshank, D, Kitchener, H

Get more information

Aetiological importance of ovulation in epithelial ovarian cancer: a population based study by Cruickshank, D J

Get full text